To prevent irritation or buildup of scar tissue, its important to rotate your injection sites
Zepbound received approval in November 2023 for chronic weight management in adults with obesity or overweight plus a weight-related condition, and in December 2024 for moderate-to-severe obstructive sleep apnea in adults with obesity
In the U.K., once supply issues are sorted out, Wegovy will only be available to severely obese adults who have at least one additional weight-related condition, such as heart disease or high blood pressure, a body mass index (BMI) of more than 35, prescribed only within an NHS-authorized specialist weight-management scheme and for a maximum of two years
The stomach is emptying more slowly
Barkmeier, MD, a retina specialist at Mayo Clinic in Rochester, Minnesota, reported at the American Society of Retina Specialists (ASRS) 2025 Annual Meeting in Long Beach, California